Peng Yu

Download
Partner Hong Kong

Peng Yu is a partner in the Corporate Department of the Firm’s Hong Kong office. He focuses his practice exclusively on private equity matters and mergers and acquisitions.

“He is an outstanding PE lawyer and has a very good reputation in the market. He has strong technical skills and is very attentive.”

—Chambers Greater China

“Peng is probably one of the best PE lawyers in the market. Very hands-on, attentive to details and also has the "big picture" commercial sense so that he can guide our team on key commercial and legal matters. We have great trust in him.”

—Legal 500 Hong Kong

Peng is widely recognized as a leading private equity and M&A lawyer in the market.  He has extensive experience in advising global and regional private equity and corporate clients on a wide range of strategically important transactions, including buyouts, take-privates, PIPEs, growth capital investments, divestitures, joint ventures and other cross-border transactions. These transactions span sectors as diverse as technology, education, health care/life sciences, consumer products, industrials, infrastructure and real estate.

Peng is consistently recognized by reputable legal publications such as Chambers, IFLR1000, Legal 500 and China Business Law Journal for his market leading private equity and M&A practice. Peng has been named a “Growth Driver” in China Business Law Journal’s annual A-List lawyers from 2023 to date and was named “TMT Lawyer of the Year” by China Law & Practice in 2018.

Peng’s recent representations include*:

  • An investor consortium in its acquisition and development of Subway’s China business, which operates the quick-service restaurant business in mainland China under the master franchise granted by the SUBWAY® brand owner. It is the largest master franchise in Subway history and reportedly one of the largest across the global quick-service-restaurant industry. This transaction was named as one of the “Deals of the Year 2023” by China Business Law Journal
  • Alibaba in multiple transactions, including (1) its take-private of BEST Inc. (NYSE: BEST); (2) US$1.15 billion investment in Farfetch (in conjunction with Richemont); (3) US$1.38 billion PIPE investment in ZTO Express; (4) US$1.4 billion take-private of iKang Healthcare; (5) PIPE investment in, and related joint venture with, Dufry AG; (6) Joint venture with Marriott; (7) strategic partnership with Richemont and joint venture with YOOX Net-A-Porter Group; and (8) various acquisitions, investments and disposals across technology and consumer sectors
  • Bain Capital in multiple matters, including (1) acquisition of World Wide Packaging; (2) acquisition of a China-based cosmetic packaging business; and (3) its auction sale of Gymboree Play & Music business
  • Baring Private Equity Asia (now known as EQT Private Capital Asia) in multiple matters, including (1) US$1 billion take-private acquisition of Ginko International; (2) acquisition, alongside Bright Food Group, and subsequent US$1.8 billion auction sale, of UK-based Weetabix Food Company; and (3) various acquisitions, investments and disposals across a number of sectors
  • Brain Asset Management in its US$500 million investment in SK pharmteco Inc., a U.S.-based leading global contract development and manufacturing organization (CDMO) under Korean conglomerate SK Inc.
  • The LYCRA Company in multiple matters, including (1) proposed multi-billion dollar sale to a Chinese buyer; and (2) joint venture with Yinchuan municipal asset management company to set up manufacturing operations in Yinchuan city to produce spandex products
  • MBK Partners in multiple matters, including (1) its acquisition, and subsequent auction sale, of Apex Logistics (this transaction was named “Private Equity Deal of the Year” by Asia Legal Awards 2022); and (2) various acquisitions, investments and disposals
  • Nexus Point Capital in its leveraged acquisition of Honour Lane Shipping Ltd. This transaction was named “Deal of the Year – Mid Cap” by AVCJ Private Equity & Venture Capital Awards 2022
  • TPG in multiple matters, including (1) joint venture and hotel acquisition project with Huazhu Hotels Group (previously known as China Lodging Group); (2) take-private of ShangPharma; and (3) various investments in China-based businesses in consumer, education and technology sectors
  • China Resources Capital in its investments in health care and infrastructure sectors
  • DST Global in its various investments in technology and consumer sectors across Asia
  • Didi Chuxing in its fundraising for its autonomous driving business
  • NetEase in its fundraising for its cloud music business and various other investments and acquisitions

*Includes matters handled prior to joining Weil.

▻
◅